Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Myfortic (sodium mycophenolate) - Important Safety Information from Novartis Ireland Ltd. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
30/11/2015
Problem Or Issue:
Important Safety Information communication from Novartis Ireland Ltd. on serious risk of teratogenicity (important new pregnancy prevention advice for women and men) associated with Myfortic (sodium mycophenolate).
Important Safety Information - Myfortic (sodium mycophenolate
« Back
Date Printed: 24/04/2024